Patient characteristics
Characteristic . | All Patients (N = 154) . | R (n = 77) . | RL (n = 77) . | |||
---|---|---|---|---|---|---|
n . | % . | n . | % . | n . | % . | |
Median (range) age, y | 62 (26-85) | 63 (29-85) | 61 (26-80) | |||
≥60 | 91 | 59 | 49 | 64 | 42 | 55 |
≥70 | 31 | 20 | 13 | 17 | 18 | 23 |
Sex | ||||||
Male | 72 | 47 | 37 | 48 | 35 | 45 |
Female | 82 | 53 | 40 | 52 | 42 | 55 |
Ann Arbor stage | ||||||
II | 19 | 12 | 8 | 10 | 11 | 14 |
III | 58 | 38 | 29 | 38 | 29 | 38 |
IV | 77 | 50 | 40 | 52 | 37 | 48 |
Performance status | ||||||
0 | 112 | 73 | 53 | 69 | 59 | 77 |
1 | 42 | 27 | 24 | 31 | 18 | 23 |
B symptoms | ||||||
Absent | 118 | 77 | 57 | 74 | 61 | 79 |
Present | 36 | 23 | 20 | 26 | 16 | 21 |
LDH* | ||||||
Normal | 119 | 77 | 59 | 77 | 60 | 78 |
Elevated | 32 | 21 | 17 | 22 | 15 | 19 |
β2MG† | ||||||
Normal | 83 | 54 | 40 | 52 | 43 | 56 |
Elevated | 60 | 39 | 30 | 39 | 30 | 39 |
Bulky disease, cm | ||||||
<6 | 91 | 59 | 46 | 60 | 45 | 58 |
≥6 | 63 | 41 | 31 | 40 | 32 | 42 |
Risk by FLIPI score | ||||||
Low | 36 | 23 | 15 | 19 | 21 | 27 |
Intermediate | 46 | 30 | 26 | 34 | 20 | 26 |
High | 72 | 47 | 36 | 47 | 36 | 47 |
Histologic grade | ||||||
1 | 38 | 25 | 18 | 23 | 20 | 26 |
2 | 91 | 59 | 46 | 60 | 45 | 58 |
3A | 25 | 16 | 13 | 17 | 12 | 16 |
Characteristic . | All Patients (N = 154) . | R (n = 77) . | RL (n = 77) . | |||
---|---|---|---|---|---|---|
n . | % . | n . | % . | n . | % . | |
Median (range) age, y | 62 (26-85) | 63 (29-85) | 61 (26-80) | |||
≥60 | 91 | 59 | 49 | 64 | 42 | 55 |
≥70 | 31 | 20 | 13 | 17 | 18 | 23 |
Sex | ||||||
Male | 72 | 47 | 37 | 48 | 35 | 45 |
Female | 82 | 53 | 40 | 52 | 42 | 55 |
Ann Arbor stage | ||||||
II | 19 | 12 | 8 | 10 | 11 | 14 |
III | 58 | 38 | 29 | 38 | 29 | 38 |
IV | 77 | 50 | 40 | 52 | 37 | 48 |
Performance status | ||||||
0 | 112 | 73 | 53 | 69 | 59 | 77 |
1 | 42 | 27 | 24 | 31 | 18 | 23 |
B symptoms | ||||||
Absent | 118 | 77 | 57 | 74 | 61 | 79 |
Present | 36 | 23 | 20 | 26 | 16 | 21 |
LDH* | ||||||
Normal | 119 | 77 | 59 | 77 | 60 | 78 |
Elevated | 32 | 21 | 17 | 22 | 15 | 19 |
β2MG† | ||||||
Normal | 83 | 54 | 40 | 52 | 43 | 56 |
Elevated | 60 | 39 | 30 | 39 | 30 | 39 |
Bulky disease, cm | ||||||
<6 | 91 | 59 | 46 | 60 | 45 | 58 |
≥6 | 63 | 41 | 31 | 40 | 32 | 42 |
Risk by FLIPI score | ||||||
Low | 36 | 23 | 15 | 19 | 21 | 27 |
Intermediate | 46 | 30 | 26 | 34 | 20 | 26 |
High | 72 | 47 | 36 | 47 | 36 | 47 |
Histologic grade | ||||||
1 | 38 | 25 | 18 | 23 | 20 | 26 |
2 | 91 | 59 | 46 | 60 | 45 | 58 |
3A | 25 | 16 | 13 | 17 | 12 | 16 |